Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer

11 May 2022

Abstract excerpt

Lymphocyte antigen 96 (LY96) is implicated in tumorigenesis by modulating host immunity. However, an integrated pan-cancer analysis of LY96 in prognosis and immunotherapy across human cancers is still lacking. Therefore, we analyzed the LY96 expression and its prognostic role in tumors by multiple databases. We also investigated the correlation between LY96 and copy number, DNA methylation, somatic mutation,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35647025
DOI: 10.3389/fmolb.2022.837393

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human CancerPMID 35647025Read ↗

Gene LY96 is an M2 macrophage‐related biomarker and is associated with immunosuppression in renal cell carcinomaSemantic proximity Read ↗

Prognostic and immunological analysis of METTL16 in pan-cancerSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancerSemantic proximity Read ↗

Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.Semantic proximity Read ↗

Immune and clinical features of CD96 expression in glioma by large-scale analysisSemantic proximity Read ↗

Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancersSemantic proximity Read ↗

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.Semantic proximity Read ↗

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer AnalysisSemantic proximity Read ↗

Focusing on the Abnormal Events of NPC1, NPC2, and NPC1L1 in Pan-Cancer and Further Constructing LUAD and KICH Prediction Models.Semantic proximity Read ↗

ZWINT is a cancer prognosis and immune infiltration-related biomarker from pan-cancer analysisSemantic proximity Read ↗

Pan-cancer Analysis Identifies LMNB1 as a Target to Redress Th1/Th2 Imbalance and Enhance PARP Inhibitor Response in Human CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.